Radially expandable endoprosthesis device with two-stage deployment

• US 20030065386A1
• Filed: 09/28/2001
• Published: 04/03/2003
• Est. Priority Date: 09/28/2001
• Status: Abandoned Application

• Current Assignee: Ethicon Incorporated (Johnson & Johnson)
• Original Assignee: Ethicon Incorporated (Johnson & Johnson)
• Inventors: Weadock, Kevin Shaun
• Application Number:
  US09/968,481
• Publication Number:
  US 20030065386A1
• Time in Patent Office: Days
• US Class Current: 623/2.38
• CPC Class Codes: A61F 2/07 Stent-grafts
• CPC Class Codes: A61F 2/2412 with soft flexible valve members, e.g. tissue valves shaped like natural valves check valves with flexible valve members in general F16K15/14
• CPC Class Codes: A61F 2/90 characterised by a net-like or mesh-like structure
• CPC Class Codes: A61F 2002/065 Y-shaped blood vessels
• CPC Class Codes: A61F 2250/0082 specially designed for children, e.g. having means for adjusting to their growth

Abstract

A radially expandable endoprosthesis device and method of deployment with an at least two stage deployment capability. More particularly, the device pertains to an annularly expandable heart valve prosthesis which is adapted for the long-term treatment of valvular diseases in infants, children and adolescents. The device is constituted of a combination of superelastic alloys and bioresorabable materials which facilitates the devices to undergo multistage deployments at predetermined intervals while emplaced in the body vessels or lumens of patients.

Claims

1. A radially expandable endoprosthesis having an at least two-stage deployment capability, said endoprosthesis comprising a heart valve prosthesis including a valve annulus which subsequent to deployment in a patient is expandable from a first diameter to at least a second larger diameter within a specified interval of time.

2. A radially expandable endoprosthesis as claimed in claim 1, wherein said endoprosthesis is constituted of a combination of a superelastic alloy and a bioresorbable material.

3. A radially expandable endoprosthesis as claimed in claim 2, wherein said superelastic alloy comprises nitinol.

4. A radially expandable endoprosthesis as claimed in claim 2, wherein said bioresorbable material comprises a coating on said superelastic alloy.

5. A radially expandable endoprosthesis as claimed in claim 2, wherein said bioresorbable material comprises a restraint means on said superelastic alloy.

6. A radially expandable endoprosthesis as claimed in claim 2, wherein said bioresorbable material is constituted of a polymer system possessing specified rates of resorption so as to enable said annulus to enter said at least second stage of additional radial expansion.

7. A radially expandable endoprosthesis as claimed in claim 2, wherein the specified interval of time for a resorption of the resorbable material is selected to be in the range of about 6 months to about 200 months at which said annulus expands to the at least second larger diameter.

8. A radially expandable endoprosthesic as claimed in claim 7, wherein said at least second larger diameter is at least 1.1 times the size of said first diameter.

9. A radially expandable endoprosthesis as claimed in claim 2, wherein said endoprosthesic comprises a coronary stent for the counteracting of restenosis.

10. A radially expandable endoprosthesis as claimed in claim 2, wherein said endoprothesis comprises a stent for the stenting of aortic aneurysms.

11. A radially expandable endoprosthesis as claimed in claim 2, wherein said bioresorbable material is selected to enable said annulus to undergo secondary and tertiary stages of expansion.

12. A radially expandable endoprosthesis as claimed in claim 6, wherein said polymer system is selected from the group of materials consisting of PLA-PGA copolymer systems, polytyrosine systems, and combinations of differing polymer systems for controllably varying the resorption rates thereof.

13. A radially expandable endoprosthesis as claimed in claim 6, wherein, wherein said polymer system contains a therapeutic agent.

14. A radially expandable endoprosthesis as claimed in claim 13, wherein said therapeutic agent selectively comprises an antibiotic, cytostatic or anticoagulant.

15. A method of deploying a radially expandable endoprosthesis having an at least two-stage deployment capability, said endoprosthesis comprising a heart valve prosthesis including a valve annulus which subsequent to deployment in a patient is expandable from a first diameter to at least a second larger diameter within a specified interval of time.

16. A method of deploying a radially expandable endoprosthesis as claimed in claim 15, wherein said endoprosthesis is constituted of a combination of a superelastic alloy and a bioresorbable material.

17. A method of deploying radially expandable endoprosthesis as claimed in claim 16, wherein said superelastic alloy comprises nitinol.

18. A method of deploying a radially expandable endoprosthesis as claimed in claim 16, wherein said bioresorbable material comprises a coating on said superelastic alloy.

19. A method of deploying a radially expandable endoprosthesis as claimed in claim 16, wherein said bioresorbable material comprises a restraint means on said superelastic alloy.

20. A method of deploying a radially expandable endoprosthesis as claimed in claim 16, wherein said bioresorbable material is constituted of a polymer system possessing specified rates of resorption so as to enable said annulus to enter said at least second stage of additional radial expansion.

21. A method of deploying a radially expandable endoprosthesis as claimed in claim 16, wherein the specified interval of time for a resorption of the resorbable material is selected to be in the range from about 6 months to about 200 months at which said annulus expands to the at least second larger diameter.

22. A method of deploying a radially expandable endoprosthesic as claimed in claim 21, wherein said at least second larger diameter is at least 1.1 times the size of said first diameter.

23. A method of deploying a radially expandable endoprosthesis as claimed in claim 16, wherein said endoprosthesic comprises a coronary stent for the counteracting of restenosis.

24. A method of deploying a radially expandable endoprosthesis as claimed in claim 16, wherein said endoprothesis comprises a stent for the stenting of aortic aneurysms.

25. A method of deploying a radially expandable endoprosthesis as claimed in claim 16, wherein said bioresorbable material is selected to enable said annulus to undergo secondary and tertiary stages of expansion.

26. A method of deploying a radially expandable endoprosthesis as claimed in claim 20, wherein said polymer system is selected from the group of materials consisting of PLA-PGA copolymer systems, polytyrosine systems, and combinations of differing polymer systems for controllably varying the resorption rates thereof.

27. A method of deploying a radially expandable endoprosthesis as claimed in claim 20, wherein said system contains a therapeutic agent.

28. A method of deploying a radially expandable endoprosthesis as claimed in claim 27, wherein said therapeutic agent selectively comprises an antibiotic, cytostatic or anticoagulant.